Topic Contents
Zinc
Uses
Zinc is an essential mineral that is a component of more than 300 enzymes needed to repair wounds, maintain fertility in adults and growth in children, synthesize protein, help cells reproduce, preserve vision, boost immunity, and protect against free radicals, among other functions.
What Are "Star" Ratings?
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.
Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.
For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.
This supplement has been used in connection with the following health conditions:
| Used for | Amount | Why |
|---|---|---|
|
Acne Vulgaris
|
60 to 90 mg daily |
Several double-blind trials indicate that taking zinc reduces acne severity. Long-term use requires 1 to 2 mg of copper per day to prevent copper deficiency.
|
|
||
| Used for | Amount | Why |
|---|---|---|
|
Acrodermatitis
|
30 to 150 mg per day under a doctor's supervision |
Supplementing with the correct amount of zinc can completely resolve hereditary acrodermatitis enteropathica |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Down’s Syndrome
|
1 mg per 2.2 lbs (1 kg) of body weight daily |
Zinc may improve immune function, reduce infection rates, and stimulate growth. Take under a doctor’s supervision. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Male Infertility and Zinc Deficiency
|
60 mg (plus 2 mg of copper, to prevent depletion) daily |
Zinc deficiency leads to reduced numbers of sperm and impotence in men. Taking zinc may correct this problem and improve sperm quality. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Night Blindness and Zinc Deficiency
|
If deficient: 15 to 30 mg daily (with 1 to 2 mg copper daily, to prevent depletion) |
A lack of zinc may reduce the activity of retinol dehydrogenase, an enzyme needed to help vitamin A work in the eye. Zinc helps night blindness in people who are zinc-deficient. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Wilson’s Disease
|
Consult a qualified healthcare practitioner |
Supplementing with zinc may help reduce dietary copper absorption. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Wound Healing
|
30 mg daily (with 2 mg copper daily to prevent depletion), or apply topical zinc preparations regularly |
Zinc is a component of enzymes needed to repair wounds, and even a mild deficiency can interfere with optimal recovery from everyday tissue damage. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Acne Rosacea
|
23 mg three times per day for three months |
In a double-blind study, zinc supplements decreased the rosacea severity by about 75%. Long-term zinc users should also take a copper supplement to prevent deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Anorexia
|
50 mg a day (with 1 to 3 mg copper daily, to protect against depletion) |
People with anorexia may be deficient in zinc, in which case supplementing with the mineral can restore levels and improve symptoms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Attention Deficit–Hyperactivity Disorder
|
If deficient: 15 mg per day |
In one study, children with ADHD who received zinc showed significantly greater behavioral improvement, compared with children who received a placebo. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Birth Defects
|
15 mg daily |
Many doctors recommend a zinc-containing multivitamin to all women of childbearing age who may become pregnant for its potential role in preventing neural tube defects. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Bulimia
|
Refer to label instructions |
People with bulimia may be deficient in zinc, in which case supplementing with the mineral can restore levels and improve symptoms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Canker Sores and Zinc Deficiency
|
150 mg daily plus 1 to 2 mg of copper per day to prevent copper deficiency |
Zinc deficiency has been linked with recurrent canker sores, so treating the deficiency may lead to relief. Long-term zinc supplementation requires extra copper to avoid deficiency.
|
|
||
| Used for | Amount | Why |
|---|---|---|
|
Celiac Disease and Zinc Deficiency
|
Consult a qualified healthcare practitioner |
The malabsorption that occurs in celiac disease can lead to multiple nutritional deficiencies. Supplementing with zinc may correct a deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Cold Sores
|
Consult a qualified healthcare practitioner |
Topically applied zinc appears to inhibit the replication of the herpes virus and help prevent future outbreaks. Use topical zinc only under a doctor’s supervision. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Crohn’s Disease
|
25 to 50 mg of zinc (with 2 to 4 mg of copper to avoid depletion) per day |
Zinc is needed to repair intestinal cells damaged by Crohn’s disease. Supplementation may offset some of the deficiency caused by Crohn’s-related malabsorption. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Genital Herpes
|
Apply a topical preparation containing 0.025 to 0.9% zinc several times per day |
Applying zinc topically may help prevent outbreaks and has been shown to stop the pain, burning, and tingling of a herpes outbreak. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Hepatitis and Hepatitis C
|
Take zinc L-carnosine supplying 17 mg zinc twice per day |
In a preliminary trial, supplementing with betaine improved signs of liver inflammation in patients with nonalcoholic steatohepatitis, a type of liver inflammation. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
HIV and AIDS Support
|
12 to 45 mg daily |
Zinc levels are frequently low in people with HIV infection. Zinc supplements have been shown to reduce the number of infections in people with AIDS. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Immune Function and Elderly People
|
25 mg daily |
Zinc supplements have been reported to increase immune function. This effect may be especially important in seniors, according to studies. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Infection
|
Refer to label instructions |
Zinc deficiencies can impair immune function. Supplementing with zinc has been shown to increase immune function in healthy people. Zinc lozenges have been found helpful in against the common cold. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Liver Cirrhosis and Zinc Deficiency
|
Take under medical supervision: 135 to 215 mg daily |
Supplementing with zinc may correct the deficiency common in alcoholic liver cirrhosis and may correct the impaired taste function that people with cirrhosis often experience. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Macular Degeneration
|
45 mg daily (with 1 to 2 mg of copper to protect against depletion) |
Two important enzymes in the retina that are needed for vision require zinc. In one trial, zinc supplementation significantly reduced the rate of visual loss in people with macular degeneration. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Peptic Ulcer
|
25 to 50 mg daily |
Supplementing with zinc may help speed the repair of damaged stomach tissue. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Peptic Ulcer
(L-Carnosine) |
150 mg of zinc carnosine complex twice per day |
Studies have shown that a zinc salt of the amino acid carnosine protects against ulcer formation and promotes the healing of existing ulcers. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Pregnancy and Postpartum Support
|
Use a prenatal supplement that includes zinc |
In one study, women who used a zinc-containing nutritional supplement before and after conception had a 36% decreased chance of having a baby with a neural tube defect. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Rheumatoid Arthritis
|
Consult a qualified healthcare practitioner |
Deficient zinc levels have been reported in people with rheumatoid arthritis. Some trials have found that supplementing with zinc reduces rheumatoid arthritis symptoms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Sickle Cell Anemia
|
Take under medical supervision: 100 mg of zinc (plus 2 mg of copper daily to protect against depletion) |
Supplementing with zinc appears to help prevent cell damage and speed healing of leg ulcers associated with sickle cell anemia. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Skin Ulcers
|
Take under medical supervision: 50 mg of zinc (plus 1 to 3 mg of copper daily, to prevent depletion) and apply zinc-containing bandages or tape to the area |
Supplementing with zinc may help some types of skin ulcer by facilitating tissue growth. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Sprains and Strains and Zinc Deficiency
|
Take under medical supervision: 25 to 50 mg daily ( plus 1 to 3 mg of copper daily, to prevent depletion) |
Zinc helps with healing. Even a mild deficiency can interfere with optimal recovery from everyday tissue damage and more serious trauma. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Thalassemia and Zinc Deficiency
|
If deficient: 22.5 to 90 mg daily |
Researchers have reported improved growth rates in zinc-deficient thalassemic children who were given zinc supplements. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Tinnitus and Zinc Deficiency
|
Take under medical supervision: 90 mg daily (with 2 or 3 mg per day of copper to prevent depletion) |
For people deficient in zinc, supplementing with zinc may help improve their tinnitus. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Type 1 Diabetes
|
Consult a qualified healthcare practitioner |
Supplementing with zinc may lower blood sugar levels and improve immune function in people with type 1 diabetes. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Type 2 Diabetes and Zinc Deficiency
|
15 to 25 mg per day |
People with type 2 diabetes tend to be zinc deficient, supplementing with zinc may help restore levels. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Warts
|
Take under medical supervision: 2.25 mg per 2.2 lbs (1 kg) body weight, up to 135 mg per day |
In one study, supplementing with zinc, resulted in complete disappearance of warts in 87% of people treated. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Athletic Performance
|
Refer to label instructions |
Exercise depletes zinc, and severe zinc deficiency can compromise muscle function. One trial found that zinc improved muscle strength, and another study of athletes with low zinc levels found that zinc improved red blood cell flexibility during exercise, which could benefit blood flow to the muscles. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Benign Prostatic Hyperplasia
|
Refer to label instructions |
Zinc has been shown to reduce prostate size in some studies. If you are taking 30 mg or more of zinc per day, most doctors recommend adding 2 to 3 mg of copper to avoid deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Childhood Diseases
|
Refer to label instructions |
Zinc is a mineral antioxidant nutrient that the immune system requires. Supplementing with it increases immune activity in people with certain illnesses. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Cystic Fibrosis
|
Refer to label instructions |
The malabsorption produced by cystic fibrosis may adversely affect zinc absorption. Supplementing with zinc can help counteract this deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Dermatitis Herpetiformis and Zinc Deficiency
|
Refer to label instructions |
Supplementing with zinc can counteract the nutrient deficiency that often occurs as a result of malabsorption. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Ear Infections
|
Refer to label instructions |
Zinc stimulates immune function, so some doctors recommend zinc supplements for people with recurrent ear infections. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Gastritis
|
Refer to label instructions |
Zinc is helpful in healing peptic ulcers, which can occur in some types of gastritis. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Gestational Hypertension
|
Refer to label instructions |
In one study, supplementing with zinc reduced the incidence of gestational hypertension in a group of pregnant Hispanic women who were not zinc deficient. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Goiter and Zinc Deficiency
|
Refer to label instructions |
Deficiencies of zinc can contribute to iodine-deficiency goiter. Supplementing with zinc may help. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Hypoglycemia
|
Refer to label instructions |
Zinc helps control blood sugar levels in diabetics, and since there are similarities in the way the body regulates high and low blood sugar levels, it might be helpful for hypoglycemia as well. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Hypothyroidism
|
Refer to label instructions |
In people with low zinc, supplementing with zinc may increased thyroid hormone levels. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Immune Function
|
Refer to label instructions |
Zinc supplements have been reported to increase immune function. Some doctors recommend zinc supplements for people with recurrent infections. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Insulin Resistance Syndrome
|
Refer to label instructions |
Low zinc intake appears to be associated with several of the risk factors common in IRS, and a low blood level of zinc is associated with insulin resistance in overweight people. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Osgood-Schlatter Disease
(Manganese, Vitamin B6) |
Refer to label instructions |
Some doctors have reported good results using a combination of zinc, manganese, and vitamin B6 for people with Osgood-Schlatter disease. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Osteoporosis
|
Refer to label instructions |
Supplementing with zinc appears to be helpful in both preventing and treating osteoporosis. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Pre- and Post-Surgery Health
|
Refer to label instructions |
Zinc is important for proper immune system function and wound healing. Zinc supplements taken before surgery may prevent zinc deficiency and promote healing. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Prostatitis
|
Refer to label instructions |
Zinc has antibacterial activity and is a key factor in the natural resistance of male urinary tract infections. Supplementing with it may improve postatitis. |
|
||
How It Works
How to Use It
Moderate intake of zinc, approximately 15 mg daily, is adequate to prevent deficiencies. Higher levels (up to 50 mg taken three times per day) are reserved for people with certain health conditions, under the supervision of a doctor. For the alleviation of cold symptoms, lozenges providing 13–25 mg of zinc in the form zinc gluconate, zinc gluconate-glycine, or zinc acetate are generally used frequently but only for several days.
Where to Find It
Good sources of zinc include oysters, meat, eggs, seafood, black-eyed peas, tofu, and wheat germ.
Possible Deficiencies
Zinc deficiencies are quite common in people living in poor countries. Phytate, a substance found in unleavened bread (pita, matzos, and some crackers) significantly reduces absorption of zinc, increasing the chance of zinc deficiency. However, phytate-induced deficiency of zinc appears to be a significant problem only for people already consuming marginally low amounts of zinc.
Even in developed countries, low-income pregnant women and pregnant teenagers are at risk for marginal zinc deficiencies. Supplementing with 25–30 mg per day improves pregnancy outcome in these groups.271 , 272
People with liver cirrhosis appear to be commonly deficient in zinc.273 This deficiency may be due to cirrhosis-related zinc malabsorption.274
People with Down’s syndrome are also commonly deficient in zinc.275 Giving zinc supplements to children with Down’s syndrome has been reported to improve impaired immunity276 and thyroid function,277 though optimal intake of zinc for people with Down’s syndrome remains unclear.
Children with alopecia areata (patchy areas of hair loss) have been reported to be deficient in zinc.278 , 279
The average diet frequently provides less than the Recommended Dietary Allowance for zinc, particularly in vegetarians. To what extent (if any) these small deficits in zinc intake create clinical problems remains unclear. Nonetheless, a low-potency supplement (15 mg per day) can fill in dietary gaps. Zinc deficiencies are more common in alcoholics and people with sickle cell anemia, malabsorption problems, and chronic kidney disease.280
Interactions
Interactions with Supplements, Foods, & Other Compounds
Zinc competes for absorption with copper, iron,281 , 282 calcium,283 and magnesium.284 A multimineral supplement will help prevent mineral imbalances that can result from taking high amounts of zinc for extended periods of time.
N-acetyl cysteine (NAC) may increase urinary excretion of zinc.285 Long-term users of NAC may consider adding supplements of zinc and copper.
Interactions with Medicines
Certain medicines interact with this supplement.
|
|
Some medicines may increase the need for this supplement. |
|---|---|
|
|
Some medicines interact with this supplement, so they should not be taken together. |
|
|
Some interactions between this supplement and certain medicines require more explanation. Click the link to see details. |
Note: The following list only includes the generic or class name of a medicine. To find a specific brand name, use the Medicines Index.
Side Effects
Side Effects
Zinc intake in excess of 300 mg per day has been reported to impair immune function.286 Some people report that zinc lozenges lead to stomach ache, nausea, mouth irritation, and a bad taste. One source reports that gastrointestinal upset, metallic taste in the mouth, blood in the urine, and lethargy can occur from chronic oral zinc supplementation over 150 mg per day,287 but those claims are unsubstantiated. In topical form, zinc has no known side effects when used as recommended.
Caution: Using zinc nasal spray has been reported to cause severe or complete loss of smell function. In some of those cases, the loss of smell was long-lasting or permanent.288
Preliminary research had suggested that people with Alzheimer’s disease should avoid zinc supplements.289 More recently, preliminary evidence in four patients actually showed improved mental function with zinc supplementation.290 In a convincing review of zinc/Alzheimer’s disease research, perhaps the most respected zinc researcher in the world concluded that zinc does not cause or exacerbate Alzheimer’s disease symptoms.291
Zinc inhibits copper absorption. Copper deficiency can result in anemia, lower levels of HDL (“good”) cholesterol, neurological disorders, and cardiac arrhythmias.292 , 293 , 294 Copper intake should be increased if zinc supplementation continues for more than a few days (except for people with Wilson’s disease).295 Some sources recommend a 10:1 ratio of zinc to copper. Evidence suggests that no more that 2 mg of copper per day is needed to prevent zinc-induced copper deficiency. Many zinc supplements include copper in the formulation to prevent zinc-induced copper deficiency. Zinc-induced copper deficiency has been reported to cause reversible anemia and suppression of bone marrow.296 In addition, there are case reports of neurologic abnormalities due to copper deficiency occurring in people who had been using large amounts of certain widely available denture creams that contained high concentrations of zinc.297
In a study of elderly people with macular degeneration, supplementing with 80 mg of zinc per day for an average of about six years increased by about 50% the incidence of hospitalizations due to genitourinary causes (such as urinary tract infections, kidney stones, and urinary retention).298 In that study, copper was also given, but in a form that cannot be absorbed by humans (cupric oxide). The reported adverse effect of zinc may have been due in large part to zinc-induced copper deficiency, which could be prevented by taking copper in a form other than cupric oxide. Nevertheless, it would be prudent for elderly people wishing to take large amounts of zinc to consult with a doctor.
Marginal zinc deficiency may be a contributing factor in some cases of anemia. In a study of women with normocytic anemia (in other words, their red blood cells were of normal size) and low total iron-binding capacity (a blood test often used to assess the cause of anemia), combined iron and zinc supplementation significantly improved the anemia, whereas iron or zinc supplemented alone had only slight effects.299 Supplementation with zinc, or zinc and iron together, has been found to improve vitamin A status among children at high risk for deficiency of the three nutrients.300
References
1. Hillström, L Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulfate and placebo in acne vulgaris. Br J Dermatol 1977;97:681–4.
2. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Dermatovener (Stockholm) 1980;60:337–40.
3. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Dermatovener (Stockholm) 1989;69:541–3.
4. Michaelsson G. Oral zinc in acne. Acta Dermatovener (Stockholm) 1980;Suppl 89:87–93 [review].
5. Michaelsson G, Juhlin L, Ljunghall K. A double blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977;97:561–6.
6. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol 1979;101:321–5.
7. Berkow R. Merck Manual. Whitehouse Station, NJ: Merck Research Laboratories, 1987, 946.
8. Teksen F, Sayli BS, Aydin A, et al. Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 1998;63:123–7.
9. Kadrabova J, Madaric A, Sustrova M, Ginter E. Changed serum trace element profile in Down’s syndrome. Biol Trace Elem Res 1996;54:201–6.
10. Neve J, Sinet PM, Molle L, Nicole A. Selenium, zinc and copper in Down’s syndrome (trisomy 21): blood levels and relations with glutathione peroxidase and superoxide dismutase. Clin Chim Acta 1983;133:209–14.
11. Purice M, Maximilian C, Dumitriu I, Ioan D. Zinc and copper in plasma and erythrocytes of Down’s syndrome children. Endocrinologie 1988;26:113–7.
12. Bruhl HH, Foni J, Lee YH, Madow A. Plasma concentrations of magnesium, lead, lithium, copper, and zinc in mentally retarded persons. Am J Ment Defic 1987;92:103–11.
13. Anneren G, Johansson E, Lindh U. Trace element profiles in individual blood cells from patients with Down’s syndrome. Acta Paediatr Scand 1985;74:259–63.
14. Stabile A, Pesaresi MA, Stabile AM, et al. Immunodeficiency and plasma zinc levels in children with Down’s syndrome: a long-term follow-up of oral zinc supplementation. Clin Immunol Immunopathol 1991;58:207–16.
15. Anneren G, Gebre-Medhin M. Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment. Hum Nutr Clin Nutr 1987;41:291–9.
16. Antila E, Nordberg UR, Syvaoja EL, Westermarck T. Selenium therapy in Down syndrome (DS): a theory and a clinical trial. Adv Exp Med Biol 1990;264:183–6.
17. Stabile A, Pesaresi MA, Stabile AM, et al. Immunodeficiency and plasma zinc levels in children with Down’s syndrome: a long-term follow-up of oral zinc supplementation. Clin Immunol Immunopathol 1991;58:207–16.
18. Licastro F, Chiricolo M, Mocchegiani E, et al. Oral zinc supplementation in Down’s syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res 1994;38:149–62.
19. Franceschi C, Chiricolo M, Licastro F, et al. Oral zinc supplementation in Down’s syndrome: restoration of thymic endocrine activity and of some immune defects. J Ment Defic Res 1988;32:169–81.
20. Lockitch G, Puterman M, Godolphin W, et al. Infection and immunity in Down syndrome: a trial of long-term low oral doses of zinc. J Pediatr 1989;114:781–7.
21. Bucci I, Napolitano G, Giuliani C, et al. Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res 1999;67:257–68.
22. Licastro F, Mocchegiani E, Zannotti M, et al. Zinc affects the metabolism of thyroid hormones in children with Down’s syndrome: normalization of thyroid stimulating hormone and of reversal triiodothyronine plasmic levels by dietary zinc supplementation. Int J Neurosci 1992;65:259–68.
23. Napolitano G, Palka G, Lio S, et al. Is zinc deficiency a cause of subclinical hypothyroidism in Down syndrome? Ann Genet 1990;33:9–15.
24. Napolitano G, Palka G, Grimaldi S, et al. Growth delay in Down syndrome and zinc sulphate supplementation. Am J Med Genet Suppl 1990;7:63–5.
25. Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984;100:367–71.
26. Kvist U, Kjellberg S, Bjorndahl L, et al. Seminal fluid from men with agenesis of the Wolffian ducts: zinc-binding properties and effects on sperm chromatin stability. Int J Androl 1990;13:245–52.
27. Saaranen M, Suistomaa U, Kantola M, et al. Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod 1987;2:475–9.
28. Danscher G, Hammen R, Fjerdingstad E, Rebbe H. Zinc content of human ejaculate and motility of sperm cells. Int J Androl 1978;1:576–81.
29. Carpino A, Siciliano L, Petroni MF, et al. Low seminal zinc bound to high molecular weight proteins in asthenozoospermic patients: evidence of increased sperm zinc content in oligoasthenozoospermic patients. Hum Reprod 1998;13:111–4.
30. Stankovic H, Mikac-Devic D. Zinc and copper in human semen. Clin Chim Acta 1976;70:123–6.
31. Hartoma TR, Nahoul K, Netter A. Zinc, plasma androgens and male sterility. Lancet 1977;2:1125–6.
32. Stankovic H, Mikac-Devic D. Zinc and copper in human semen. Clin Chim Acta 1976;70:123–6.
33. Kynaston HG, Lewis-Jones DI, Lynch RV, Desmond AD. Changes in seminal quality following oral zinc therapy. Andrologia 1988;20:21–2.
34. Tikkiwal M, Ajmera RL, Mathur NK. Effect of zinc administration on seminal zinc and fertility of oligospermic males. Indian J Physiol Pharmacol 1987;31:30–4.
35. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975:26:1057–63.
36. Omu AE, Dashti H, Al-Othman S. Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol 1998;79:179–84.
37. Anonymous. Zinc-responsive night blindness in sickle cell anemia. Nutr Rev 1982;40:175–7.
38. Hoogenraad TU, Van den Hammer CJA, Van Hattum J. Effective treatment of Wilson’s disease with oral zinc sulphate: two case reports. Br Med J 1984;289:273–6.
39. Cossack ZT. The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson’s disease. N Engl J Med 1988;318:322–3 [letter/review].
40. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson’s disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264–78.
41. Brewer GJ, Yuzbasiyan-Gurkan V. The use of zinc-copper metabolic interactions in the treatment of Wilson’s disease. J Am Coll Nutr 1989;8:452 [abstract 103].
42. Hoogenraad TU. Zinc treatment of Wilson’s Disease. J Lab Clin Med 1998;132:240–1 [editorial].
43. Brewer GJ, Hill GM, Dick RD, et al. Treatment of Wilson’s disease with zinc. III. Prevention of reaccumulation of hepatic copper. J Lab Clin Med 1987;109:526–31.
44. Brewer GJ, Yuzbasiyan-Gurkan V. Use of zinc-copper metabolic interactions in the treatment of Wilson’s disease. J Am Coll Nutr 1990;9:487–91.
45. Brewer JG, Yuzbasiyan-Gurkan V, Lee D-Y, Appelman H. Treatment of Wilson’s disease with zinc. VI. Initial treatment studies. J Lab Clin Med 1989;114:633–8.
46. Van den Hamer CJA, Hoogenraad TU. Copper deficiency in Wilson’s disease. Lancet 1989;ii:442 [letter].
47. Van Caillie-Bertrand M, Degenhart HJ, Visser HKA, et al. Oral zinc sulphates for Wilson’s disease. Arch Dis Child 1985;60:656–9.
48. Brewer JG, Yuzbasiyan-Gurkan V, Lee D-Y, Appelman H. Treatment of Wilson’s disease with zinc. VI. Initial treatment studies. J Lab Clin Med 1989;114:633–8.
49. Brewer GJ, Johnson VD, Dick RD, et al. Treatment of Wilson’s disease with zinc. XVII: treatment during pregnancy. Hepatology 2000;31:364–70.
50. Sandstead HH. Understanding zinc: Recent observations and interpretations. J Lab Clin Med 1994;124:322–7.
51. Liszewski RF. The effect of zinc on wound healing: a collective review. J Am Osteopath Assoc 1981;81:104–6 [review].
52. Pories WJ, Henzel JH, Rob CG, Strain WH. Acceleration of healing with zinc sulfate. Ann Surg 1967;165:432–6.
53. Lansdown ABG. Zinc in the healing wound. Lancet 1996;347:706–7 [editorial].
54. Ågren MS. Studies on zinc in wound healing. Acta Derm Venereol Suppl 1990;154:1–36 [review].
55. Ågren MS. Zinc in wound repair. Arch Dermatol 1999;135:1273–4 [letter].
56. Sharquie KE, Najim RA, Al-Salman HN. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol 2006;45:857–61.
57. Humphries L, Vivian B, Stuart M, McClain CJ. Zinc deficiency and eating disorders. J Clin Psychiatry 1989;50:456–9.
58. Varela P, Marcos A, Navarro MP. Zinc status in anorexia nervosa. Ann Nutr Metab 1992;36:197–202.
59. Roijen SB, Worsaae U, Zlotnik G. Zinc in patients with anorexia nervosa. Ugeskr Laeger 1991;153:721–3 [in Danish].
60. McClain CJ, Stuart MA, Vivian B, et al. Zinc status before and after zinc supplementation of eating disorder patients. J Am Coll Nutr 1992;11:694–700.
61. Safai-Kutti S. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr Scand Suppl 1990;361:14–7.
62. Birmingham CL, Goldner Em, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord 1994;15:251–5.
63. Katz RL, Keen CL, Litt IF, et al. Zinc deficiency in anorexia nervosa. J Adolesc Health Care 1987;8:400–6.
64. Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 2004;4:9.
65. Velie EM, Block G, Shaw GM, et al. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol 1999;150:605–16.
66. Hambidge M, Hackshaw A, Wald N. Neural tube defects and serum zinc. Br J Obstet Gynaecol 1993;100:746–9.
67. Berger MM, Baines M, Raffoul W, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr 2007;85:1293–300.
68. Pang JF. Relation between treatment with traditional Chinese medicine for recurrent aphthous ulcer and human zinc and copper. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12:280–2, 260–1 [in Chinese].
69. Endre L. Recurrent aphthous ulceration with zinc deficiency and cellular immune deficiency. Oral Surg Oral Med Oral Pathol 1991;72:559–61.
70. Merchant HW, Gangarosa LP, Glassman AB, Sobel RE. Zinc sulfate supplementation for treatment of recurring oral ulcers. South Med J 1977;70:559–61.
71. Wray D. A double-blind trial of systemic zinc sulfate in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1982;53:469–72.
72. Connon JJ. Celiac disease. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease, 8th ed. Philadelphia: Lea & Febiger, 1994, 1062.
73. Crofton RW, Glover SC, Ewen SWB, et al. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983;38:706–12.
74. Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr 1976;29:371–5.
75. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996;6:453–61.
76. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Med Hypotheses 1985;17:157–65.
77. Brody I. Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Dermatol 1981;104:191–4.
78. Apisariyakulm A, Buddhasukh D, Apisariyakul S, Ternai B. Zinc monoglycerolate is effective against oral herpetic sores. Med J Aust 1990;152:54.
79. Imes S, Plinchbeck BR, Dinwoodie A, et al. Iron, folate, vitamin B-12, zinc, and copper status in out-patients with Crohn’s disease: effect of diet counseling. J Am Dietet Assoc 1987;87:928–30.
80. Sandstead HH. Zinc deficiency in Crohn’s disease. Nutr Rev 1982;40:109–12.
81. Driscoll RH Jr, Meredith SC, Sitrin M, et al. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology 1982;83:1252–8.
82. Arens M, Travis S. Zinc salts inactivate clinical isolates of herpes simplex virus in-vitro. J Clin Microbiol 2000;38:1758–62.
83. Wahba A. Topical application of zinc solutions: A new treatment for herpes simplex infections of the skin? Acta Derm Venereol 1980;60:175–7.
84. Finnerty EF. Topical zinc in the treatment of herpes simplex. Cutis 1986;37:130–1.
85. Brody I. Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Derm 1981;104:191–4.
86. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Med Hypotheses 1985;17:157–65.
87. Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat 2001;8:367–71.
88. Fabris N, Mocchegiani E, Galli M, et al. AIDS, zinc deficiency, and thymic hormone failure. JAMA 1988;259:839–40.
89. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 1994;91:181–6.
90. Mocchegiani E, Veccia S, Ancarani F, et al. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995;17:719–27.
91. Baum MK, Lai S, Sales S, et al. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis 2010;50:1653–60.
92. Pike J, Chandra RK. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vitam Nutr Res 1995;65:117–21.
93. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992;340:1124–7.
94. Chavance M, Herbeth B, Lemoine A, et al. Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial. Int J Vitam Nutr Res 1993;63:11–6.
95. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98–107.
96. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998;68:365–71.
97. Fraker PJ, Gershwin ME, Good RA, Prasad A. Interrelationships between zinc and immune function. Fed Proc 1986;45:1474–9.
98. Prasad AS, Beck FWJ, Bao B, et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007;85:837–44.
99. Taniguchi S, Kaneto K, Hamada T. Acquired zinc deficiency associated with alcoholic liver cirrhosis. Int J Dermatol 1995;34:651–2.
100. Scholmerich J, Lohle E, Kottgen E, Gerok W. Zinc and vitamin A deficiency in liver cirrhosis. Hepatogastroenterology 1983;30:119–25.
101. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 1984;2(8401):493–5.
102. Marchesini G, Fabbri A, Bianchi G, et al. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996;23:1084–92.
103. Sturniolo GC, D’Inca R, Parisi G, et al. Taste alterations in liver cirrhosis: are they related to zinc deficiency? J Trace Elem Electrolytes Health Dis 1992;6:15–9.
104. Weismann K, Christensen E, Dreyer V. Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med Scand 1979;205(5):361–6.
105. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol 1988:106:192–8.
106. Stur M, Tihl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophtholmol 1966;37:1225–35.
107. Pfeiffer CJ, Cho CH, Cheema A, Saltman D. Reserpine-induced gastric ulcers: protection by lysosomal stabilization due to zinc. Eur J Pharmacol 1980;61:347–53.
108. Jimenez E, Bosch F, Galmes JL, Banos JE. Meta-analysis of efficacy of zinc acexamate in peptic ulcer. Digestion 1992;51:18–26.
109. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;2:793–6.
110. Nishiwaki H, Kato S, Sugamoto S, et al. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc. J Physiol Pharmacol 1999;50:183–95.
111. Arakawa T, Satoh H, Nakamura A, et al. Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2. Dig Dis Sci 1990;35:559–66.
112. Cho CH, Ogle CW. A correlative study of the antiulcer effects of zinc sulphate in stressed rats. Eur J Pharmacol 1978;48:97–105.
113. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;2:793–6.
114. Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxicillin, and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13(4):483–7.
115. Velie EM, Block G, Shaw GM, et al. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol 1999;150:605–16.
116. Aaseth J, Munthe E, Forre O, Steinnes E. Trace elements in serum and urine of patients with rheumatoid arthritis. Scand J Rheumatol 1978;7:237–40.
117. Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976;ii:539–42.
118. Peretz A, Neve J, Jeghers O, Pelen F. Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases. Am J Clin Nutr 1993;57:690–4.
119. Job C, Menkes CJ, de Gery A, et al. Zinc sulphate in the treatment of rheumatoid arthritis. Arthrit Rheum 1980;23:1408.
120. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents Actions 1981;8(suppl):587–96.
121. Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol 1989;32:161–6.
122. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
123. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and carotenoid levels in sickle cell disease patients. Am J Med Sci 1990;229:13–5.
124. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vitro. Clin Chim Acta 1985;149:257–61.
125. Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, Bowen P. Low serum levels of carotenoids in sickle cell anemia. Eur J Haematol 1988;41:131–5.
126. Essein, EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia. Centr Afr J Med 1995;41:48–50.
127. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anemia. East Afr Med J 1990;67:720–5.
128. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia. Am J Hematol 1992;41:227–31.
129. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr 1980;33:968–71.
130. Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr 1991;54:736–44.
131. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001;85:966–74.
132. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001;85:966–74.
133. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr 1995;45:198–203.
134. Brewer GJ, Brewer LF, Prasad AS. Suppression of irreversibly sickled erythrocytes by zinc therapy in sickle cell anemia. J Lab Clin Med 1977;90:549–54.
135. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. Lancet 1970;2:891–3.
136. Bao B, Prasad AS, Beck FWJ, et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 2008;152:67–80.
137. Williams CM, Lines CM, McKay EC. Iron and zinc status in multiple sclerosis patients with pressure sores. Eur J Clin Nutr 1988;42:321–8.
138. Greaves MW, Skillen AW. Effects of long-continued ingestion of zinc sulphate in patients with venous leg ulceration. Lancet 1970;2:889–91.
139. Carruthers R. Oral zinc sulphate in leg ulcers. Lancet 1969;1:1264.
140. Haeger K, Lanner E, Magnusson PO. Oral zinc sulfate in the treatment of venous leg ulcers. In: Pories WJ, Strain WH, Hwu JM, et al (eds), Clinical applications of zinc metabolism. Springfield, IL: CC Thomas, 1974, 158–67.
141. Hallbook T, Lanner E. Serum-zinc and healing of venous leg ulcers. Lancet 1972;2:780–2.
142. Greaves MW, Ive FA. Double-blind trial of zinc sulphate in the treatment of chronic venous leg ulceration. Br J Dermatol 1972;87:632–4.
143. Clayton RJ. Double-blind trial of oral zinc sulphate in patients with leg ulcers. Br J Clin Pract 1972;26:368–70.
144. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. Lancet 1970;2:891–3.
145. Mathur NK, Bumb RA. Oral zinc in the trophic ulcers of leprosy. Int J Lepr 1983;51:410–1.
146. Agren MS. Studies on zinc in wound healing. Acta Derm Venerol Suppl 1990;154:1–36.
147. Stromberg HE, Agren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 1984;111:461–8.
148. Eriksson G. Comparison of two occlusive bandages in the treatment of venous leg ulcers. Br J Dermatol 1986;114:227–30.
149. Agren MS, Stromberg HE. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide. Scand J Plast Reconstr Surg 1985;19:97–100.
150. Stacey MC, Jopp-Mckay AG, Rashid P, et al. The influence of dressings on venous ulcer healing—a randomised trial. Eur J Vasc Endovasc Surg 1997;13:174–9.
151. Soderberg T, Hallmans G, Stenstrom S, et al. Treatment of leprosy wounds with adhesive zinc tape. Lepr Rev 1982;53:271–6.
152. Walton RT, Fritschi EP, Umapathy VA. Treatment of plantar ulcers in leprosy patients in the community with adhesive zinc tape. Lepr Rev 1986;57:53–6.
153. Sandstead HH. Understanding zinc: Recent observations and interpretations. J Lab Clin Med 1994;124:322–7.
154. Tenaud I, Sainte-Marie I, Jumbou O, et al. In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese. Br J Dermatol 1999;140:26–34.
155. Pereira CE, Felcman J. Correlation between five minerals and the healing effect of Brazilian medicinal plants. Biol Trace Elem Res 1998;65:251–9.
156. Carlisle EM. Silicon as an essential trace element in animal nutrition. Ciba Found Symp 1986;121:123–39.
157. Leach RM. Role of manganese in mucopolysaccharide metabolism. Fed Proc 1971;30:991.
158. Palmieri L, Ronca F, Malengo S, Bertelli A. Protection of beta-thalassaemic erythrocytes from oxidative stress by propionyl carnitine. Int J Tissue React 1994;16:121–9.
159. Yesilipek MA, Hazar V, Yegin O. L-Carnitine treatment in beta thalassemia major. Acta Haematol 1998;100:162–3.
160. Saraya AK, Kumar R, Kailash S, Sehgal AK. Vitamin B12 and folic acid deficiency in b-heterozygous thalassemia. Indian J Med Res 1984;79:783–8.
161. Silprasert A, Laokuldilok T, Kulapongs P. Zinc deficiency in b-thalassemic children. In Fucharoen S, Rowley PT, Paul NW, eds. Thalassemia: pathophysiology and management, part A. New York: Alan R Liss, 1988 [review].
162. Bashir NA. Serum zinc and copper levels in sickle cell anaemia and beta-thalassaemia in North Jordan. Ann Trop Paediatr 1995;15:291–3.
163. Arcasoy A, Cavdar AO, Cin S, et al. Effects of zinc supplementation on linear growth in beta thalassemia. Am J Hematol 1987;24:127–36.
164. Akar N, Berberoglu M, Arcasoy A. Effects of zinc supplementation on somatomedin-C level, in beta-thalassemia. Am J Hematol 1992;41:142–3 [letter].
165. Cohen L, Bitterman H, Froom P, Aghai E. Decreased bone magnesium in beta thalassemia with spinal osteoporosis. Magnesium 1986;5:43–6.
166. Hyman CB, Ortega JA, Costin G, Takahashi M. The clinical significance of magnesium depletion in thalassemia. Ann N Y Acad Sci 1980;344:436–43.
167. Arcasoy A, Cavdar AO. Changes of trace minerals (serum iron, zinc, copper and magnesium) in thalassemia. Acta Haematol 1975;53:341–6.
168. De Franceschi L, Cappellini MD, Graziadei G, et al. The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia. Haematologica 1998;83:118–25.
169. Shambaugh GE. Zinc and presbycusis. Am J Otol 1985;6:116–7.
170. Paaske PB, Pedersen CB, Kjems G, Sam IL. Zinc in the management of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 1991;100:647–9.
171. Paaske PB, Kjems G, Pedersen CB, Sam ILK. Zinc in the management of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 1991;100:647–9.
172. Ochi K, Ohashi T, Kinoshita H, et al. The serum zinc level in patients with tinnitus and the effect of zinc treatment. Nippon Jibiinkoka Gakkai Kaiho 1997;100:915–9 [in Japanese].
173. Nakamura T, Higashi A, Nishiyama S, et al. Kinetics of zinc status in children with IDDM. Diabetes Care 1991;14:553–7.
174. Mocchegiani E, Boemi M, Fumelli P, Fabris N. Zinc-dependent low thymic hormone level in type I diabetes. Diabetes1989;12:932–7.
175. Rao KVR, Seshiah V, Kumar TV. Effect of zinc sulfate therapy on control and lipids in type I diabetes. J Assoc Physicians India 1987;35:52 [abstract].
176. Cunningham JJ, Fu A, Mearkle PL, Brown RG. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism1994;43:1558–62.
177. Nakamura T, Higashi A, Nishiyama S, et al. Kinetics of zinc status in children with IDDM. Diabetes Care 1991;14:553–7.
178. Niewoehner CB, Allen JI, Boosalis M, et al. Role of zinc supplementation in type II diabetes mellitus. Am J Med 1986;81:63–8.
179. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002;146:423–31.
180. Yaghoobi R, Sadighha A, Baktash D. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol 2009;60:706–8.
181. Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr 2000;72:585S–93S [review].
182. Van Loan MD, Sutherland B, Lowe NM, et al. The effects of zinc depletion on peak force and total work of knee and shoulder extensor and flexor muscles. Int J Sport Nutr 1999;9:125–35.
183. Manore MM. Dietary recommendations and athletic menstrual dysfunction. Sports Med 2002;32:887–901 [review].
184. Micheletti A, Rossi R, Rufini S. Zinc status in athletes: relation to diet and exercise. Sports Med 2001;31:577–82 [review].
185. Krotkiewski M, Gudmundsson M, Backstrom P, Mandroukas K. Zinc and muscle strength and endurance. Acta Physiol Scand 1982;116:309–11.
186. Khaled S, Brun JF, Cassanas G, et al. Effects of zinc supplementation on blood rheology during exercise. Clin Hemorheol Microcirc 1999;20:1–10.
187. Bush IM, Berman E, Nourkayhan S, et al. Zinc and the prostate. Presented at the annual meeting of the American Medical Association Chicago, 1974.
188. Fahim MS, Fahim Z, Der R, Harman J. Zinc treatment for reduction of hyperplasia of prostate. Fed Proc 1976;35(3):361.
189. Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000;130:1399S-406S [review].
190. Coutsoudis A, Coovadia HM, Broughton M, et al. Micronutrient utilisation during measles treated with vitamin A or placebo. Int J Vitam Nutr Res 1991;61:199–204.
191. Mocchegiani E, Muzzioli M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 2000;130:1424S–31S.
192. Novick SG, Godfrey JC, Pollack RL, Wilder HR. Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants. Med Hypotheses 1997;49:347–57 [review].
193. Kumel G, Schrader S, Zentgraf H, Brendel M. Therapy of banal HSV lesions: molecular mechanisms of the antiviral activity of zinc sulfate. Hautarzt 1991;42:439–45 [review; in German].
194. Krebs NF, Sontag M, Accurso FJ, Hambidge KM. Low plasma zinc concentrations in young infants with cystic fibrosis. J Pediatr 1998;133:761–4.
195. Abdulhamid I, Beck FWJ, Millard S, et al. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol 2008;43:281–7.
196. Yancy KB, Lawley TJ. “Immunologically Mediated Skin Diseases.”Harrison’s Online. 1999. http://www.harrisonsonline.com/hill-bin/Chapters.cgi (Jan 10, 2000).
197. Kastrup W, Mobacken H, Stockbrugger R, et al. Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia. Acta Med Scand 1986;220:261–8.
198. Gawkrodger DJ, Ferguson A, Barnetson RS. Nutritional status in patients with dermatitis herpetiformis. Am J Clin Nutr 1988;48:355–60.
199. Hoffbrand AV, Douglas AP, Fry L, Stewart JS. Malabsorption of dietary folate (Pteroylpolyglutamates) in adult coeliac disease and dermatitis herpetiformis. Br Med J 1970;4:85–9.
200. Davies MG, Marks R, Nuki G. Dermatitis herpetiformis—a skin manifestation of a generalized disturbance in immunity. Q J Med 1978;47:221–48.
201. Kastrup W, Mobacken H, Stockbrugger R, et al. Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia. Acta Med Scand 1986;220:261–8.
202. Crofton RW, Glover SC, Ewen SW, et al. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983;38:706–12.
203. Gawkrodger DJ, Ferguson A, Barnetson RS. Nutritional status in patients with dermatitis herpetiformis. Am J Clin Nutr 1988;48:355–60.
204. Hoffbrand AV, Douglas AP, Fry L, Stewart JS. Malabsorption of dietary folate (Pteroylpolyglutamates) in adult coeliac disease and dermatitis herpetiformis. Br Med J 1970;4:85–9.
205. Di Stefano M, Jorizzo RA, Veneto G, et al. Bone mass and metabolism in dermatitis herpetiformis. Dig Dis Sci 1999;44:2139–43.
206. Duchateau J, Delespesse G, Vereecke P. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr 1981;34:88–93.
207. Fraker PJ, Gershwin ME, Good RA, Prasad A. Interrelationships between zinc and immune function. Fed Proc 1986;45:1474–9.
208. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;22(21):793–6.
209. Hunt IF, Murphy NJ, Cleaver AE, et al. Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low-income women of Mexican descent. Am J Clin Nutr 1984;40:508–21.
210. Ozata M, Salk M, Aydin A, et al. Iodine and zinc, but not selenium and copper, deficiency exists in a male Turkish population with endemic goiter. Biol Trace Elem Res 1999;69:211–6.
211. Kawada J, Nishida M, Yoshimura Y, Yamashita K. Manganese ion as a goitrogen in the female mouse. Endocrinol Jpn 1985;32:635–43.
212. Kawada J, Nishida M, Yoshimura Y, Yamashita K. Manganese ion as a goitrogen in the female mouse. Endocrinol Jpn 1985;32:635–43.
213. Untoro J, Ruz M, Gross R. Low environmental selenium availability as an additional determinant for goiter in East Java, Indonesia? Biol Trace Elem Res 1999;70:127–36.
214. Corvilain B, Contempre B, Longombe AO, et al. Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 1993;57:244S–248S [review].
215. Vanderpas JB, Contempre B, Duale NL, et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am J Clin Nutr 1993 Feb;57(2 Suppl):271S–275S [review].
216. Roti E, Minelli R, Gardini E, et al. Selenium administration does not cause thyroid insufficiency in subjects with mild iodine deficiency and sufficient selenium intake. J Endocrinol Invest 1993;7:481–4.
217. Zimmermann MB, Adou P, Torresani T, et al. Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. Eur J Clin Nutr 2000;3:209–13.
218. Anderson RA et al. Chromium supplementation of humans with hypoglycemia. Fed Proc 1984;43:471.
219. Stebbing JB et al. Reactive hypoglycemia and magnesium. Magnesium Bull 1982;2:131–4.
220. Shansky A. Vitamin B3 in the alleviation of hypoglycemia. Drug Cosm Ind 1981;129(4):68–69,104–5.
221. Gaby AR, Wright JV. Nutritional regulation of blood glucose. J Advancement Med 1991;4:57–71.
222. Fujimoto S, Indo Y, Higashi A, et al. Conversion of thyroxine into tri-iodothyronine in zinc deficient rat liver. J Pediatr Gastroenterol Nutr 1986;5:799–805.
223. Hartoma TR, Sotaniemi EA, Maattanen J. Effect of zinc on some biochemical indices of metabolism. Nutr Metab 1979;23:294–300.
224. Weismann K, Roed-Petersen J, Hjorth N, Kopp H. Chronic zinc deficiency syndrome in a beer drinker with a Billroth II resection. Int J Dermatol 1976;15:757–61.
225. Wolf WR, Holden J, Greene FE. Daily intake of zinc and copper from self selected diets. Fed Proc 1977;36:1175.
226. Pike J, Chandra RK. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vitam Nutr Res 1995;65:117–21.
227. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992;340:1124–7.
228. Chavance M, Herbeth B, Lemoine A, et al. Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial. Int J Vitam Nutr Res 1993;63:11–6.
229. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98–107.
230. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998;68:365–71.
231. Duchateau J, Delespesse G, Vereecke P. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr 1981;34:88–93.
232. Fraker PJ, Gershwin ME, Good RA, Prasad A. Interrelationships between zinc and immune function. Fed Proc 1986;45:1474–9.
233. Fortes C, Forastiere F, Agabiti N, et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998;46:19–26.
234. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98–107.
235. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252:1443–6.
236. Macknin ML. Zinc lozenges for the common cold. Cleveland Clin J Med 1999;66:27–32 [review].
237. Singh RB, Niaz MA, Rastogi SS, et al. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998;17:564–70.
238. Chen MD, Lin PY, Lin WH. Investigation of the relationships between zinc and obesity. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1991;7:628–34 [in Chinese].
239. Aston B. Manganese and man. J Orthomolec Psychiatry 1980;9:237–49.
240. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. J Reprod Med 1990;35:503–7.
241. Sahap AO. Zinc and senile osteoporosis. J Am Geriatr Soc 1983;31:790–1.
242. Relea P, Revilla M, Ripoll E, et al. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 1995; 24:303–7.
243. Elmståhl S, Gullberg B, Janzon L, et al. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int 1998;8:333–40.
244. Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060–4.
245. Thomas DR. Specific nutritional factors in wound healing. Adv Wound Care 1997;10:40–3 [review].
246. Stotts NA, Whitney JD. Nutritional intake and status of clients in the home with open surgical wounds. J Community Health Nurs 1990;7:77–86.
247. Yamamoto R, Inoue K, Hori T, et al. Clinical evaluation of changes in serum zinc and copper concentrations around pulmonary operation. Nippon Kyobu Geka Gakkai Zasshi 1994;42:1178–83 [in Japanese].
248. Cordova Martinez A, Escanero Marcen JF. Changes in serum trace elements after surgery: value of copper and zinc in predicting post-operative fatigue. J Int Med Res 1992;20:12–9.
249. Yamamoto R, Inoue K, Hori T, et al. Clinical evaluation of changes in serum zinc and copper concentrations around pulmonary operation. Nippon Kyobu Geka Gakkai Zasshi 1994;42:1178–83 [in Japanese].
250. Cordova Martinez A, Escanero Marcen JF. Changes in serum trace elements after surgery: value of copper and zinc in predicting post-operative fatigue. J Int Med Res 1992;20:12–9.
251. Senapati A, Slavin BM, Thompson RPH. Zinc depletion and complications of surgery. Clinical Nutrition 1990;9:341–6.
252. Hallbook T, Hedelin H. Pre-operative peroral zinc supplementation. Acta Chir Scand 1978;144:63–6.
253. Lazebnik N, Kuhnert BR, Kuhnert PM. Zinc, cadmium, and hypertension in parturient women. J Obstet Gynecol 1989;161:437–40.
254. Cherry FF, Bennett EA, Bazzano GS, et al. Plasma zinc in hypertension/toxemia and other reproductive variables in adolescent pregnancy. Am J Clin Nutr 1981;34:2367–75.
255. Simmer K, Iles CA, James C, Thompson RP. Are iron-folate supplements harmful? Am J Clin Nutr 1987;45:122–5.
256. Hunt IF, Murphy NJ, Cleaver AE, et al. Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low-income women of Mexican descent. Am J Clin Nutr 1984;40:508–21.
257. Mahomed K, James DK, Golding J, McCabe R. Zinc supplementation during pregnancy: a double-blind randomised controlled trial. BMJ 1989;299:826–9.
258. Jonsson B, Hauge B, Larsen MF, Hald F. Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand 1996;75:725–9.
259. Colleen S, Mardh PA, Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol 1975;9:192–7.
260. Fair WR, Parrish RF. Antibacterial substances in prostatic fluid. Prog Clin Biol Res 1981;75A:247–64.
261. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].
262. Colleen S, Mardh PA, Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol 1975;9:192–7.
263. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor. Identity and significance. Urology 1976;7:169–77.
264. Kavanagh JP, Darby C, Costello CB. The response of seven prostatic fluid components to prostatic disease. Int J Androl 1982;5:487–96.
265. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975;26:1057–63.
266. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].
267. Neal DE Jr, Kaack MB, Fussell EN, Roberts JA. Changes in seminal fluid zinc during experimental prostatitis. Urol Res 1993;21:71–4.
268. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975;26:1057–63.
269. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor. Identity and significance. Urology 1976;7:169–77.
270. Bush IM, Berman E, Nourkayhan S, et al. Zinc and the prostate. Presented at the annual meeting of the American Medical Association Chicago, 1974.
271. Cherry FF, Sandstead HH, Rojas P, et al. Adolescent pregnancy: associations among body weight, zinc nutriture, and pregnancy outcome. Am J Clin Nutr 1989;50:945–54.
272. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc supplementation on pregnancy outcome. JAMA 1995;274:463–8.
273. Scholmerich J, Lohla E, Gerok W. Zinc and vitamin A deficiency in liver cirrhosis. Hepatogastroenterology 1983;30:119–25.
274. Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci 1988;33:1096–102.
275. Stabile A, Pesaresi MA, Stabile AM, et al. Immunodeficiency and plasma zinc levels in children with Down’s syndrome: a long-term follow-up of oral zinc supplementation. Clin Immunol Immunopathol 1991;58:207–16.
276. Björksten B, Back O, Gustavson KH, et al. Zinc and immune function in Down’s syndrome. Acta Paediatr Scand 1980;69:183–7.
277. Bucci I, Napolitano G, Guiliani C, et al. Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res 1999;67;257–68.
278. Wollowa F, Jablonska S. Zinc in the treatment of alopecia areata. In: Kobori Y, Montagna W (eds). Biology and Diseases of the Hair. Tokyo: University Park Press, 1976, 305.
279. Lutz G. The value of zinc in treatment of alopecia areata. 2nd Meeting of the European Hair Research Society, Bologna, April 14, 1991.
280. Prasad A. Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 1991;53:403–12 [review].
281. Dawson EB, Albers J, McGanity WJ. Serum zinc changes due to iron supplementation in teen-age pregnancy. Am J Clin Nutr 1990;50:848–52.
282. Crofton RW, Gvozdanovic D, Gvozdanovic S, et al. Inorganic zinc and the intestinal absorption of ferrous iron. Am J Clin Nutr 1989;50:141–4.
283. Argiratos V, Samman S. The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects. Eur J Clin Nutr 1994;48:198–204.
284. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr 1994;13:479–84.
285. Brumas V, Hacht B, Filella M, Berthon G. Can N-acetyl-L-cysteine affect zinc metabolisms when used as a paracetamol antidote? Agents Actions 1992;36:278–88.
286. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252:1443.
287. Shannon M. Alternative medicines toxicology: a review of selected agents. Clin Toxicol 1999;37:709–13
288. Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc gluconate use. Am J Rhinol 2004;18:137–41.
289. Bush AI, Pettingell WH, Multhaup G, et al. Rapid induction of Alzheimer A8 amyloid formation by zinc. Science 1994;265:1464–5.
290. Potocnik FCV, van Rensburg SJ, Park C, et al. Zinc and platelet membrane microviscosity in Alzheimer’s disease. S Afr Med J 1997;87:1116–9.
291. Prasad AS. Zinc in human health: an update. J Trace Elem Exp Med 1998;11:63–87.
292. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion-a reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990;264:1441–3.
293. Reiser S, Powell A, Yang CY, Canary JJ. Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr Rep Int 1987;36:641–9.
294. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 1995;61(suppl):621S–24S [review].
295. Fischer PWF, Giroux A, Labbe MR. Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 1984;40:743–6.
296. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990;264:1441–3.
297. Nations SP, Boyer PJ, Love LA, et al. Denture cream. An unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008;71:639–43.
298. Johnson AR, Munoz A, Gottlieb JL, Jarrard DF. High dose zinc increases hospital admissions due to genitourinary complications. J Urol 2007;177:639-43.
299. Nishiyama S, Irisa K, Matsubasa T, et al. Zinc status relates to hematological deficits in middle-aged women. J Am Coll Nutr 1998;17:291–5.
300. Muñoz EC, Rosado JL, Lopez P, et al. Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers. Am J Clin Nutr 2000;71:789–94.
Last Review: 08-17-2011
Copyright © 2011 Aisle7. All rights reserved. www.Aisle7.net
Learn more about Aisle7, the company.
The information presented in Aisle7 is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires June 2013.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
